Advanced glycation end-products and advanced oxidation protein products in schizophrenia.
Antioxidants
Oxidative stress
Schizophrenia
Journal
Psychiatry research
ISSN: 1872-7123
Titre abrégé: Psychiatry Res
Pays: Ireland
ID NLM: 7911385
Informations de publication
Date de publication:
05 2022
05 2022
Historique:
received:
29
07
2021
revised:
21
02
2022
accepted:
20
03
2022
pubmed:
29
3
2022
medline:
20
4
2022
entrez:
28
3
2022
Statut:
ppublish
Résumé
Schizophrenia pathophysiology is still not well understood. Genetic factors involving biochemical systems are key players and oxidative stress takes part to the development and worsening of SZ. Oxidative stress led to the permanent production of oxidation products such as advanced glycation end products (AGEs) and advanced oxidation protein products (AOPPs). These proteins interact with their receptor amplifying ROS production and pro-inflammatory cytokines sustaining a permanent loop. We tested plasma levels of AGEs and AOPPs in 30 SZ patients. Their levels were statistically higher than controls confirming their involvement in mental disorders. Antioxidant nutraceuticals and a healthy lifestyle could diminish oxidative stress and ameliorate SZ symptoms.
Identifiants
pubmed: 35344686
pii: S0165-1781(22)00141-X
doi: 10.1016/j.psychres.2022.114527
pii:
doi:
Substances chimiques
Advanced Oxidation Protein Products
0
Biomarkers
0
Glycation End Products, Advanced
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
114527Informations de copyright
Copyright © 2022. Published by Elsevier B.V.